Dr. Reddy’s Laboratories launches Vozet Tablets in Indian market

19 Jul 2017 Evaluate

Dr. Reddy’s Laboratories has launched Vozet Tablets in Indian market. The drug is indicated for the treatment of allergic Rhinitis and chronic Urticaria. Vozet Tablets contain Levocetirizine 5 mg, and are available in a strip size of 10 tablets.

The anti-histamine market in India had sales of Rs 1,038 crore MAT for the most recent twelve months ended in March 2017, according to IMS data. The pharma major will further strengthen its anti-allergy portfolio with the addition of Vozet.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×